S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17

National Health Investors (NHI) Stock Forecast, Price & News

+1.78 (+3.21%)
(As of 05/17/2022 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
273,542 shs
Average Volume
279,257 shs
Market Capitalization
$2.62 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive NHI News and Ratings via Email

Sign-up to receive the latest news and ratings for National Health Investors and its competitors with MarketBeat's FREE daily newsletter.

National Health Investors logo

About National Health Investors

Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.


See More Headlines

Industry, Sector and Symbol

Real estate investment trusts
Specialized REITs
Year Founded

Sales & Book Value

Annual Sales
$298.71 million
Cash Flow
$4.51 per share
Book Value
$33.08 per share


Net Income
$111.80 million
Pretax Margin




Free Float
Market Cap
$2.62 billion

Company Calendar

Ex-Dividend for 5/6 Dividend
Dividend Payable
Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Social Links


Overall MarketRank

1.78 out of 5 stars

Finance Sector

849th out of 1,377 stocks

Real Estate Investment Trusts Industry

184th out of 235 stocks

Analyst Opinion: 1.1Community Rank: 3.9Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

National Health Investors (NYSE:NHI) Frequently Asked Questions

Is National Health Investors a buy right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for National Health Investors in the last year. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" National Health Investors stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NHI, but not buy additional shares or sell existing shares.
View analyst ratings for National Health Investors
or view top-rated stocks.

Are investors shorting National Health Investors?

National Health Investors saw a increase in short interest in April. As of April 30th, there was short interest totaling 1,980,000 shares, an increase of 24.5% from the April 15th total of 1,590,000 shares. Based on an average daily trading volume, of 263,200 shares, the short-interest ratio is currently 7.5 days. Approximately 4.5% of the company's stock are sold short.
View National Health Investors' Short Interest

When is National Health Investors' next earnings date?

National Health Investors is scheduled to release its next quarterly earnings announcement on Monday, August 8th 2022.
View our earnings forecast for National Health Investors

How were National Health Investors' earnings last quarter?

National Health Investors, Inc. (NYSE:NHI) announced its quarterly earnings results on Monday, May, 9th. The real estate investment trust reported $0.18 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.63 by $0.45. The real estate investment trust earned $71.33 million during the quarter, compared to analysts' expectations of $73.06 million. National Health Investors had a trailing twelve-month return on equity of 5.55% and a net margin of 29.35%. National Health Investors's revenue was down 11.8% on a year-over-year basis. During the same period in the previous year, the firm earned $1.24 earnings per share.
View National Health Investors' earnings history

How often does National Health Investors pay dividends? What is the dividend yield for National Health Investors?

National Health Investors announced a quarterly dividend on Monday, May 9th. Shareholders of record on Thursday, June 30th will be paid a dividend of $0.90 per share on Friday, August 5th. This represents a $3.60 dividend on an annualized basis and a yield of 6.29%. The ex-dividend date is Wednesday, June 29th.
View National Health Investors' dividend history

Is National Health Investors a good dividend stock?

National Health Investors pays an annual dividend of $3.60 per share and currently has a dividend yield of 6.49%. NHI has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of National Health Investors is 195.65%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, National Health Investors will have a dividend payout ratio of 78.43% in the coming year. This indicates that National Health Investors may not be able to sustain their current dividend.
View National Health Investors' dividend history.

What guidance has National Health Investors issued on next quarter's earnings?

National Health Investors issued an update on its FY 2022 earnings guidance on Monday, May, 16th. The company provided earnings per share guidance of $4.32-$4.42 for the period. The company issued revenue guidance of -.

What price target have analysts set for NHI?

5 brokers have issued 1 year price objectives for National Health Investors' shares. Their forecasts range from $51.00 to $72.00. On average, they anticipate National Health Investors' share price to reach $62.00 in the next year. This suggests a possible upside of 8.3% from the stock's current price.
View analysts' price targets for National Health Investors
or view top-rated stocks among Wall Street analysts.

Who are National Health Investors' key executives?
National Health Investors' management team includes the following people:
  • Mr. D. Eric Mendelsohn, Pres, CEO & Director (Age 60, Pay $776.54k)
  • Mr. John L. Spaid, Exec. VP of Fin. & CFO (Age 62, Pay $483.7k)
  • Mr. Kevin Carlton Pascoe, Chief Investment Officer (Age 41, Pay $432.71k)
  • Mr. David Louis Travis, Sr. VP & Chief Accounting Officer (Age 47, Pay $297.2k)
  • Ms. Kristin Sallee Gaines, Chief Credit Officer (Age 50, Pay $372.43k)
  • Mr. Dana Rolfson Hambly, Director of Investor Relations
  • Mr. Kimberly Ouimet, Director of Corp. Compliance & HR
  • Ms. Michelle R. Kelly, Sr. VP of Investments
  • Susan V. Sidwell, Corp. Sec.
  • Ms. Colleen Schaller, Real Estate Transaction Mang.
What other stocks do shareholders of National Health Investors own?

Based on aggregate information from My MarketBeat watchlists, some companies that other National Health Investors investors own include AT&T (T), AbbVie (ABBV), Verizon Communications (VZ), Cisco Systems (CSCO), Annaly Capital Management (NLY), JPMorgan Chase & Co. (JPM), Simon Property Group (SPG), Energy Transfer (ET), QUALCOMM (QCOM) and Broadcom (AVGO).

What is National Health Investors' stock symbol?

National Health Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "NHI."

Who are National Health Investors' major shareholders?

National Health Investors' stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (13.97%), BlackRock Inc. (9.40%), State Street Corp (4.77%), Sumitomo Mitsui Trust Holdings Inc. (1.87%), Bank of New York Mellon Corp (1.78%) and American Century Companies Inc. (1.54%). Company insiders that own National Health Investors stock include Robert G Adams and Robert T Webb.
View institutional ownership trends for National Health Investors

Which major investors are selling National Health Investors stock?

NHI stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., BlackRock Inc., CapWealth Advisors LLC, CapWealth Advisors LLC, CapWealth Advisors LLC, First Trust Advisors LP, Citigroup Inc., and Principal Financial Group Inc..
View insider buying and selling activity for National Health Investors
or view top insider-selling stocks.

Which major investors are buying National Health Investors stock?

NHI stock was purchased by a variety of institutional investors in the last quarter, including State Street Corp, LSV Asset Management, Sumitomo Mitsui Trust Holdings Inc., Comerica Bank, American Century Companies Inc., Rush Island Management LP, Renaissance Technologies LLC, and Vanguard Group Inc.. Company insiders that have bought National Health Investors stock in the last two years include Robert G Adams, and Robert T Webb.
View insider buying and selling activity for National Health Investors
or or view top insider-buying stocks.

How do I buy shares of National Health Investors?

Shares of NHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is National Health Investors' stock price today?

One share of NHI stock can currently be purchased for approximately $57.23.

How much money does National Health Investors make?

National Health Investors has a market capitalization of $2.62 billion and generates $298.71 million in revenue each year. The real estate investment trust earns $111.80 million in net income (profit) each year or $1.84 on an earnings per share basis.

How many employees does National Health Investors have?

National Health Investors employs 19 workers across the globe.

When was National Health Investors founded?

National Health Investors was founded in 1991.

What is National Health Investors' official website?

The official website for National Health Investors is www.nhireit.com.

How can I contact National Health Investors?

National Health Investors' mailing address is 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129. The real estate investment trust can be reached via phone at (615) 890-9100, via email at [email protected], or via fax at 615-225-3030.

This page was last updated on 5/18/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.